Recombinant Protein Vaccine AUC Analysis

Recombinant protein vaccines are a type of vaccine that do not contain a complete pathogen and are made from specific protein antigens produced by heterologous expression systems. Common heterologous expression systems include bacteria, mammalian cells, plant cells, and insect cells, and the appropriate heterologous expression system needs to be selected according to the type of antigen produced. Due to their excellent safety, stability, and low cost, recombinant protein vaccines have been widely favored by researchers in recent years. Currently, recombinant protein vaccines have been widely used in various infectious diseases, such as preventing hepatitis B virus (HBV), tetanus, whooping cough, influenza, and so on.

 

Analytical Ultracentrifugation (AUC) is widely used in the research and development of recombinant protein vaccines. AUC uses centrifugal force and centrifugal time to analyze the sedimentation behavior of molecules in the solution, providing important information about the structure, interactions, and purity of proteins.

 

Specific Applications of AUC in Recombinant Protein Vaccines

1. Protein Purity and Aggregate Analysis

2. Study of Interactions and Complex Formation of Recombinant Protein Vaccines

3. Evaluation of Protein Stability and Aggregate Kinetics

4. Quality Control in the Development of Recombinant Protein Vaccines

 

MtoZ Biolabs provides high-resolution, high-sensitivity recombinant protein vaccine AUC technology services for you. This technology is widely used in the research and development process of recombinant protein vaccines, providing important information about the structure, interactions, purity, stability, and aggregate kinetics of proteins. This information is of great significance for the research and development, quality control, and efficacy evaluation of protein drugs.